4-aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls

American Journal of Epidemiology

Volumn 147, Issue 3, 1998, Pages 315-323

  Wang, Li Yu ^a,b   Chen, Chien Jen ^b   Zhang, Yu Jing ^a   Tsai, Wei Yann ^a   Lee, Po Huang ^c   Feitelson, Mark A ^d   Lee, Chue Shue ^c   Santella, Regina M ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Aminobiphenyl compounds; Carcinoma, hepatocellular; Liver neoplasms; Smoking

Indexed keywords

4 BIPHENYLAMINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; FEMALE; HUMAN; HUMAN TISSUE; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TAIWAN;

EID: 2642621559     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009452     Document Type: Article

References (46)

1. Health statistics 1994. Taipei, Taiwan: Department of Health, Executive Yuan, Republic of China, 1994.
2. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hemotol 1994;17:71-91.
3. Ross RK, Yuan JM, Yu MC, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-6.
4. 1-DNA adducts. Cancer Epidemiol Biomarkers Prev 1996;5:613-19.
5. Wang LY, Hatch M, Chen CJ, et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer 1996;67:620-5.
6. 1-DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma. Hepatology 1992;16:1150-5.
7. Chen CJ, Liang KY, Chang AS, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991;13:398-406.
8. Yu MW, Chen CJ, Luo JC, et al. Correlations of chronic hepatitis B virus infection and cigarette smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma. Cancer Res 1994;54:5106-10.
9. Hirayama T. A large-scale cohort study on risk factors for primary liver cancer, with special reference to the role of cigarette smoking. Cancer Chemother Pharmacol 1989;23(suppl):S114-17.
10. Yu MC, Tong MJ, Govindarajan S, et al. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
11. Hoffmann D, Rivenson A, Chung FL, et al. Potential inhibitors of tobacco carcinogenesis. Ann N Y Acad Sci 1993;686:140-60.
12. Bartsch H, Malaveille C, Friesen M, et al. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV. Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 1993;29A:1199-207.
13. Butler MA, Iwasaki M, Guengerich FP, et al. Human cytochrome P-450PA (P-4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A 1989;86:7696-700.
14. 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography. Carcinogenesis 1990;11:639-46.
15. Kadlubar FF. DNA adducts of carcinogenic aromatic amines. In: Hemminki K, Dipple A, Shuker DE, et al. DNA adducts: identification and biological significance. (IARC Scientific Publication no. 125). New York, NY: Oxford University Press, 1994:199-215.
16. Poirier MC, Fullerton NF, Smith BA, et al. DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. Carcinogenesis 1995;16:2917-21.
17. Vineis P, Bartsch H, Caporaso N, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994;369:154-6.
18. Yu MC, Skipper PL, Taghizadeh K, et al. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst 1994;86:712-16.
19. Yu MC, Ross RK, Chan KK, et al. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black, and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1995;4:861-4.
20. Lin D, Lay JO Jr, Bryant MS, et al. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatographymass spectrometry. Environ Health Perspect 1994;102(suppl 6):11-16.
21. al-Atrash J, Zhang YJ, Lin D, et al. Quantitative immunohistochemical analysis of 4-aminobiphenyl-DNA in cultured cells and mice: comparison to gas chromatography/mass spectroscopy analysis. Chem Res Toxicol 1995;8:747-52.
22. Hsu TM, Zhang YJ, Santella RM. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1997;6:193-9.
23. Curigliano G, Zhang YJ, Wang LY, et al. Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers. Carcinogenesis 1996;17:911-16.
24. Feitelson MA, Zhu M, Duan LX, et al. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from primary hepatocellular carcinoma. Oncogene 1993;8:1109-17.
25. Wang XW, Forrester K, Yeh H, et al. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A 1994;91:2230-4.
26. Zhang YJ, Hsu TM, Santella RM. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in oral mucosa cells of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1995;4:133-8.
27. Feitelson MA. Products of the "X" gene in hepatitis B and related viruses. Hepatology 1986;6:191-8.
28. Daly AK, Cholerton S, Gregory W, et al. Metabolic polymorphisms. Pharmacol Ther 1993;57:129-60.
29. Nakajima M, Yokoi T, Mizutani M, et al. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol Biomarkers Prev 1994;3:413-21.
30. Blum M, Demierre A, Grant DM, et al. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci U S A 1991;88:5237-41.
31. Landi MT, Zocchetti C, Bernucci I, et al. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev 1996;5:693-8.
32. Catteau A, Bechtel YC, Poisson N, et al. A population and family study of CYP1A2 using caffeine urinary metabolites. Eur J Clin Pharmcol 1995;47:423-30.
33. Kall MA, Vang O, Clausen J. Effects of dietary broccoli on human in vivo drug metabolizing enzymes: evaluation of caffeine, oestrone and chlorzoxazone metabolism. Carcinogenesis 1996;17:793-9.
34. Sinha R, Rothman N, Brown ED, et al. Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytohrome P4501A2 activity in humans. Cancer Res 1994;54:6154-9.
35. Denaro CP, Wilson M, Jacob P 3rd, et al. The effect of liver disease on urine caffeine metabolite ratios. Clin Pharmacol Ther 1996;59:624-35.
36. Guengerich FP, Turvy CG. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J Pharmacol Exp Ther 1991;256:1189-94.
37. George J, Murray M, Byth K, et al. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995;21:120-8.
38. Colombo M, de Franchis R, del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-80.
39. Chen DS, Kuo GC, Sung JL, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990;162:817-22.
40. Jeng JE, Tsai JF. Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol 1991;34:74-7.
41. Hashimoto Y, Degawa M. Induction of cytochrome P450 isoforms by carcinogenic aromatic amines and carcinogenic susceptibility of rodent animals. Pharmacogenetics 1995;5(suppl):S80-3.
42. 14C-caffeine breath test. Pharmacol Toxicol 1995;77:247-9.
43. International Agency for Research on Cancer and World Health Organization. Tobacco smoking. (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, vol 38). Lyon, France: International Agency for Research on Cancer, 1986:122.
44. Stavenuiter JF, Verrips-Kroon M, Bos EJ, et al. Syntheses of 5-phenyl-2-pyridinamine, a possibly carcinogenic pyrolysis product of phenylalanine, and some of its putative metabolites. Carcinogenesis 1985;6:13-19.
45. Bryant MS, Skipper PL, Tannenbaum SR, et al. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 1987;47:602-8.
46. 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary TV-oxidation, conjugation, and peroxidation. Mutat Res 1997;378:97-112.